Figure 1.
The effects of missing self between donors and recipients on clinical outcomes. The cumulative incidence estimates for the probability of molecular (A) and haematologic (B) relapse, as well as the Kaplan–Meier estimate for event-free survival (EFS, C) for CML patients lacking or expressing of the relevant KIR ligand (HLA-BW4 or HLA-C2 positive) for the donor-inhibitory KIR gene (group A, n=74 or group B, n=23) after haploidentical T-cell-replete transplantation.